PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2341334-3	1990	Pretreatment of the lungs with a noninjurious dose of PAF (1.6 nM) 10 min before protamine markedly potentiated protamine-induced pulmonary vasoconstriction and resulted in severe lung edema and increased lung tissue content of 6-keto-prostaglandin F1 alpha, thromboxane B2, and leukotriene C4.	Leukotriene C4	279-293	PCNA clamp associated factor	Rattus norvegicus	54-57	
8242237-13	1993	When PAF receptors were activated by PAF in the perfused heart, significant amounts of leukotriene C4 and leukotriene C4/D4/E4 were detected in the coronary effluent.	Leukotriene C4	87-101	PCNA clamp associated factor	Rattus norvegicus	5-8	
8242237-13	1993	When PAF receptors were activated by PAF in the perfused heart, significant amounts of leukotriene C4 and leukotriene C4/D4/E4 were detected in the coronary effluent.	Leukotriene C4	87-101	PCNA clamp associated factor	Rattus norvegicus	37-40	
2888915-2	1987	The inhibition was shown to be specific and competitive with PAF on its receptor by the following observations: parallel shift of the dose-response curve; crossing of double reciprocal plots on the intersection of the ordinate; and no inhibition on other autacoids such as bradykinin, histamine, 5-hydroxytryptamine and LTC4.	Leukotriene C4	320-324	PCNA clamp associated factor	Rattus norvegicus	61-64	
11934880-1	2002	Platelet activating factor (PAF) interacts with cell surface G protein-coupled receptors on leukocytes to induce degranulation, leukotriene C(4) (LTC(4)) generation, and chemokine CCL2 production.	Leukotriene C4	128-141	PCNA clamp associated factor	Rattus norvegicus	28-31